Clinical Trial Hopes to Improve Mesothelioma Diagnosis Accuracy

Researchers doing a clinical trial in Scotland are hoping to improve mesothelioma diagnosis accuracy. In turn these would help to better treat patients by uncovering the issue earlier in patients.

The trial which goes by the name, Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) will focus on comparing boimarkers in the blood of patients to see which are the most useful.

Mesothelioma is one of the most difficult cancers to diagnose and treat which is why the focus is on early detection. Any delay in diagnosing patients can and does lead to late treatment and we all know the consequences of that, which is why this is such important research.